DFSVX | RYTRX | DFSVX / RYTRX | |
Total Expense Ratio | 0.31 | 1.26 | 25% |
Annual Report Gross Expense Ratio | 0.31 | 1.26 | 25% |
Fund Existence | 32 years | 31 years | - |
Gain YTD | -12.795 | -10.227 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.9B | 857M | 1,622% |
Annual Yield % from dividends | 1.65 | 3.00 | 55% |
Returns for 1 year | -5.06 | -4.31 | 117% |
Returns for 3 years | 3.93 | -11.28 | -35% |
Returns for 5 years | 101.19 | -5.38 | -1,881% |
Returns for 10 years | 23.87 | -46.70 | -51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 22.06 | 0.38 | +1.76% |
iShares Neuroscience and Healthcare ETF | |||
XJUN | 38.04 | 0.41 | +1.09% |
FT Vest US Eq Enh&Mod Bffr ETF June | |||
SPBO | 28.71 | 0.24 | +0.84% |
SPDR® Portfolio Corporate Bond ETF | |||
PTMC | 34.67 | 0.04 | +0.10% |
Pacer Trendpilot™ US Mid Cap ETF | |||
MKOR | 22.02 | N/A | N/A |
Matthews Korea Active ETF |